Moreover, there is evidence that HOXA10 could activate PI3K/Akt pathway in human hepatocellular carcinoma and chronic myelogenous leukemia [7, 8]. Here, HOXA10 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.